Attention deficit hyperactivity disorder: More than a child's disease

Formulary

Volumn 45, Issue 10, 2010, Pages 318-327

  Mohundro, Brice Labruzzo ^a   Wicker, Ann McMahon ^a  

^a UNIVERSITY OF LOUISIANA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ATOMOXETINE; CENTRAL STIMULANT AGENT; CLONIDINE; DESIPRAMINE; DEXAMPHETAMINE; DEXMETHYLPHENIDATE; GUANFACINE; LISDEXAMFETAMINE; METHYLPHENIDATE; MIXED AMPHETAMINE SALT; MODAFINIL; PEMOLINE; PLACEBO; UNCLASSIFIED DRUG;

ANOREXIA; ANXIETY; ARTICLE; ATTENTION DEFICIT DISORDER; ATTENTION DISTURBANCE; BEHAVIOR THERAPY; CHILDHOOD DISEASE; COMORBIDITY; CONSTIPATION; DECREASED APPETITE; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIARRHEA; DRUG ABSORPTION; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG HALF LIFE; DRUG INDUCED HEADACHE; DRUG MECHANISM; DRUG METABOLISM; DRUG SAFETY; EMPLOYMENT STATUS; HUMAN; HYPERACTIVITY; HYPERTENSION; IMPULSIVENESS; INSOMNIA; LACTATION; NAUSEA; NERVOUSNESS; PATIENT EDUCATION; POPULATION; PREGNANT WOMAN; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEXUALLY TRANSMITTED DISEASE; SIDE EFFECT; SMOKING; SUBSTANCE ABUSE; TIME TO MAXIMUM PLASMA CONCENTRATION; UNITED STATES; XEROSTOMIA;

EID: 78651291228     PISSN: 1082801X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Kessler RC, Adler L, Barkley R, et al. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry. 2006;163:716-723.
2. Moss SB, Nair R, Vallarino A, Wang S. Attention deficit/hyperactivity disorder in adults. Prim Care Clin Office Pract. 2007;34:445-473.
3. Greydanus DE, Pratt HD, Patel DR. Attention deficit hyperactivity disorder across the lifespan: the child, adolescent, and adult. Dis Mon. 2007;53:70-131.
4. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Text Revision. Washington, DC: American Psychiatric Association, 2000.
5. Searight HR, Burke JM, Rottnek F. Adult ADHD: evaluation and treatment in fami ly medicine. Am Fam Physician. 2000;62:2077-2086, 2091-2092.
6. Katragadda S, Schubiner H. ADHD in children, adolescents and adults. Prim Care Clin Office Pract. 2007;34:317-341.
7. Facts & Comparisons E Answers. Methylphenidate hydrochloride. Available at: http://online.factsandcomparisons.com/MonoDisp.aspx?monoid=fandc- hcp10002&book=DFC. Accessed October 29, 2010.
8. Krishnan SM, JG Stark. Multiple daily-dose pharmacokinetics of lisdexamfetamine dimesylate in healthy adult volunteers. Curr Med Res Opin. 2008;24:33-40.
9. Spencer T, Wilens T, Biederman J, Faraone SV, Ablon JS, Lapey K. A doubleblind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder. Arch Gen Psychiatry. 1995;52:434-443.
10. Faraone SV, Spencer T, Aleardi M, Pagano C, Biederman J. Meta-analysis of the efficacy of methylphenidate for treating adult attention-deficit/ hyperactivity disorder. J Clin Psychopharmacol. 2004;24:24-29.
11. ClinicalTrials.gov. Methylphenidate transdermal system (MTS) in the treatment of adult ADHD. Available at: http://clinicaltrials.gov/ct2/show/ NCT00506285. Accessed October 29, 2010.
12. Adler LA, Zimmerman B, Starr HL, et al. Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder. A randomized, placebocontrolled, double-blind, parallel group, dose-escalation study. J Clin Psychopharmacol. 2009;29:239-247.
13. Moen MD, Keam SJ. Dexmethylphenidate extended release. A review of its use in the treatment of attention-deficit hyperactivity disorder. CNS Drugs. 2009;23:1057-1083.
14. Spencer TJ, Adler LA, McGough JJ, et al. Efficacy and safety of dexmethylphenidate extended-release capsules in adults with attention deficit/hyperactivity disorder. Biol Psychiatry. 2007;61:1380-1387.
15. Adler LA, Spencer T, McGough JJ, Jiang H, Muniz R. Long-term effectiveness and safety of dexmethylphenidate extendedrelease capsules in adult ADHD. J Atten Disord. 2009;12:449-459.
16. Krishnan SM, Pennick M, Stark JG. Metabolism, distribution and elimination of lisdexamfetamine dimesylate. Clin Drug Invest. 2008;28:745-755.
17. Popovic B, Bhattacharya P, Sivaswamy L. Lisdexamfetamine: a prodrug for the treatment of attention-deficit/hyperactivity disorder. Am J Health-Syst Pharm. 2009;66:2005-2012.
18. Adler LA, Goodman DW, Kollins SH, et al; on behalf of the 303 Study Group. Double-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/ hyperactivity disorder. J Clin Psychiatry. 2008;69:1364-1373.
19. Wigal T, Brams M, Gasior M, et al; 316 Study Group. Randomized, double-blind, placebo-controlled, crossover study of the eff icacy and safety of lisdexamfetamine dimesylate in adults with at tent ion-deficit /hyperactivity disorder: novel findings using a simulated adult workplace environment design. Behav Brain Funct. 2010;6:34.
20. Weisler RH, Biederman J, Spencer TJ, et al; on behalf of the 303 Study Group. Mixed amphetamine salts extended-release in the treatment of adult ADHD: a randomized, controlled trial. CNS Spectr. 2006;11:625-639.
21. Weiss M, Murray C. Assessment and management of attention-deficit hyperactivity disorder in adults. CMAJ. 2003;168:715-722.
22. Michelson D, Adler L, Spencer T, et al. Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies. Biol Psychiatry. 2003;53:112-120.
23. Reimherr FW, Hedges DW, Strong RE, Marchant BK, Williams ED. Bupropion SR in adults with ADHD: a short-term, placebo-controlled trial. Neuropsychiatr Dis Treat. 2005;1:245-251.
24. Wilens TE, Haight BR, Horrigan JP, et al. Bupropion XL in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled study. Biol Psychiatry. 2005;57:793-801.
25. Wilens TE. Mechanism of action of agents used in attention-deficit/ hyperactivity disorder. J Clin Psychiatry. 2006;67(suppl 8):32-37.
26. Wilens TE, Biederman J, Prince J, et al. Six-week, double-blind, placebo-controlled study of desipramine for adult attention deficit hyperactivity disorder. Am J Psychiatry. 1996;153:1147-1153.
27. Turner DC, Clark L, Dowson J, Robbins TW, Sahakian BJ. Modafinil improves cognition and response inhibition in adult attention-deficit/hyperactivity disorder. Biol Psychiatry. 2004;55:1031-1040.
28. Taylor FB, Russo J. Efficacy of modafinil compared to dextroamphetamine for the treatment of attention deficit hyperactivity disorder in adults. J Child Adolesc Psychopharmacol. 2000;10:311-320.
29. Stern TA, Rosenbaum JF, Fava M, Biederman J, Rauch SL. Massachusetts General Hospital Comprehensive Clinical Psychiatry. 1st ed. Phi ladelphia, PA: Mosby; Available at: http://www.mdconsult.com. Accessed October 29, 2010.
30. Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation. 8th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2008.
31. Humphreys C, Garcia-Bournissen F, Ito S, Koren G. Exposure to attention deficit hyperactivity disorder medications during pregnancy. Can Fam Physician. 2007;53:1153-1155.